Shares of Danaher Corporation (NYSE:DHR - Get Free Report) have earned an average rating of "Moderate Buy" from the twenty-five research firms that are covering the firm, Marketbeat.com reports. Five analysts have rated the stock with a hold recommendation, nineteen have issued a buy recommendation and one has assigned a strong buy recommendation to the company. The average 12-month price objective among brokerages that have issued ratings on the stock in the last year is $228.9130.
A number of research firms recently weighed in on DHR. Deutsche Bank Aktiengesellschaft reaffirmed a "buy" rating and issued a $240.00 price target on shares of Danaher in a report on Wednesday, July 22nd. HSBC cut their price objective on Danaher from $270.00 to $230.00 and set a "buy" rating for the company in a research report on Wednesday, June 3rd. Wall Street Zen downgraded Danaher from a "buy" rating to a "hold" rating in a research note on Saturday, April 25th. Evercore reissued an "outperform" rating and issued a $230.00 price target on shares of Danaher in a research note on Monday, July 6th. Finally, Stifel Nicolaus cut their price target on shares of Danaher from $260.00 to $220.00 and set a "buy" rating for the company in a report on Wednesday, July 22nd.
Check Out Our Latest Analysis on Danaher
Danaher Stock Up 2.2%
DHR opened at $216.14 on Friday. Danaher has a fifty-two week low of $160.93 and a fifty-two week high of $242.80. The company has a debt-to-equity ratio of 0.48, a quick ratio of 1.25 and a current ratio of 1.65. The company has a fifty day moving average of $195.01 and a two-hundred day moving average of $192.43. The stock has a market capitalization of $151.94 billion, a price-to-earnings ratio of 38.39, a PEG ratio of 2.63 and a beta of 0.78.
Danaher (NYSE:DHR - Get Free Report) last issued its quarterly earnings data on Monday, July 20th. The conglomerate reported $1.94 earnings per share for the quarter, topping analysts' consensus estimates of $1.85 by $0.09. Danaher had a net margin of 15.95% and a return on equity of 11.04%. The business had revenue of $6.26 billion during the quarter, compared to the consensus estimate of $6.12 billion. During the same quarter in the prior year, the firm posted $0.77 earnings per share. The company's revenue was up 5.5% compared to the same quarter last year. On average, research analysts expect that Danaher will post 8.53 earnings per share for the current year.
Institutional Trading of Danaher
Several institutional investors have recently modified their holdings of DHR. High Note Wealth LLC grew its position in shares of Danaher by 19.2% in the fourth quarter. High Note Wealth LLC now owns 292 shares of the conglomerate's stock valued at $67,000 after purchasing an additional 47 shares during the last quarter. First Command Advisory Services Inc. raised its position in shares of Danaher by 4.4% during the 4th quarter. First Command Advisory Services Inc. now owns 1,104 shares of the conglomerate's stock worth $253,000 after purchasing an additional 47 shares during the last quarter. GW&K Investment Management LLC lifted its stake in Danaher by 8.4% in the 4th quarter. GW&K Investment Management LLC now owns 605 shares of the conglomerate's stock valued at $138,000 after buying an additional 47 shares in the last quarter. Kestra Private Wealth Services LLC lifted its stake in Danaher by 0.3% in the 3rd quarter. Kestra Private Wealth Services LLC now owns 15,421 shares of the conglomerate's stock valued at $3,057,000 after buying an additional 48 shares in the last quarter. Finally, SOL Capital Management CO grew its holdings in Danaher by 2.7% during the 4th quarter. SOL Capital Management CO now owns 1,879 shares of the conglomerate's stock valued at $430,000 after buying an additional 50 shares during the last quarter. Institutional investors and hedge funds own 79.05% of the company's stock.
Danaher Company Profile
(
Get Free Report)
Danaher Corporation NYSE: DHR is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.
Products and services in Danaher's portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.
Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Danaher, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Danaher wasn't on the list.
While Danaher currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.